- The global yeast infection market focuses on the diagnosis, treatment, and prevention of infections caused by Candida species, particularly Candida albicans, which commonly affects the skin, mouth, genitals, and bloodstream
- The Growth is primarily driven by factors such as the rising incidence of immunocompromised conditions (for instance, HIV/AIDS, diabetes), increased antibiotic usage, and expanding awareness of women’s health and hygiene
- North America is expected to dominate the yeast infections market with a market share of 42.5 %, due to high prevalence of conditions such as diabetes, which increases susceptibility to yeast infections, along with advanced healthcare infrastructure and strong public awareness campaigns
- Asia-Pacific is expected to be the fastest growing region in the yeast infection market with a market share of 22.5%, during the forecast period due to rapid expansion of healthcare infrastructure, growing awareness about yeast infections, and rising surgical volumes in the region
- Candida albicans segment is expected to dominate the market with a market share of 85.7% due to its high prevalence as the primary causative agent in most yeast infections, especially vaginal and oral candidiasis
